Neuroblastoma: Symptoms, Causes, Treatments, Diagnosis

Neuroblastoma: Symptoms, Causes, Treatments, Diagnosis

Neuroblastoma is a rare form of cancer that affects young children. This cancer usually originates in

the adrenal glands, which are located above the kidneys. However, it can also develop in other areas of

the body like the nerves in the neck, chest, abdomen, and pelvis. Neuroblastoma is notorious for being

difficult to treat and can metastasize rapidly, making early detection crucial in treatment and prognosis.

The symptoms of neuroblastoma range from vague symptoms, such as weight loss and irritability, to more

severe symptoms, such as pain, swelling, and bone fractures. Due to the complexity of neuroblastoma, a

range of methods for diagnosis and treatment is required. This essay will review the symptoms, causes,

diagnosis, and treatment options for neuroblastoma, aiming to provide a comprehensive overview of this

disease.

- Brief overview of neuroblastoma

Neuroblastoma is a type of cancer that usually develops in young children. It occurs when nerve cells in

the embryonic stage fail to mature properly and become tumors, usually in the adrenal glands that sit atop

the kidneys or in the nerve tissues of the neck, abdomen, or chest. Neuroblastoma is a rare disease, and

only about 800 children in the United States are diagnosed with it each year. It usually affects children

under the age of five and is rare in adults. Some children might be born with the tumor, while others

develop it over time. The disease is classified into different stages based on how far it has spread and

how much it has metastasized. The prognosis for children with neuroblastoma depends on several factors,

including the age of the child, the stage of the cancer, and the extent to which the disease has metastasized.

Research is ongoing to find better treatments for the disease and to improve the survival rates of children

with neuroblastoma.

- Importance of discussing neuroblastoma

In conclusion, discussing neuroblastoma is crucial to raise awareness of this cancer and the need for

early diagnosis and specialized treatment. Due to the complexity of the disease, a shared understanding

of the diagnosis, symptoms, and treatment options is critical for healthcare professionals, families, and

patients alike. Furthermore, early detection of neuroblastoma is key for successful management, as the

prognosis worsens with disease progression. By openly discussing neuroblastoma, we can reduce the

stigma surrounding childhood cancers and encourage more support and resources for families and patients

affected by this disease. Additionally, discussing the latest research and treatments for neuroblastoma

helps healthcare professionals understand the most effective ways to treat the disease, leading to improved

outcomes for patients. Ultimately, by discussing neuroblastoma, we can work towards raising awareness,

improving treatment options, and ultimately, saving lives.

Neuroblastoma has a wide range of treatment options which vary depending on the location, stage,

and size of the tumor. Surgery is the primary option, and it is often used to remove the tumor and

all surrounding affected tissue. In some cases, chemotherapy and radiation therapy are necessary as

adjuvant treatments to help destroy any residual cancer cells that may be left after surgery. Additionally,

immunotherapy may be offered to help the patient's immune system recognize and destroy any remaining

cancer cells. Targeted therapy drugs that affect specific molecules in cancer cells may also be prescribed.

Clinical trials for new medications or innovative treatment options may be available to eligible patients.

Regular follow-up appointments and imaging tests will be needed to ensure the tumor does not return and

to monitor any ongoing side effects of treatment. In some cases, long-term management may be necessary

to prevent potential late effects of treatment.

II. Symptoms of Neuroblastoma

The symptoms of neuroblastoma depend on where the tumor is located and how large it has grown. Most

often, neuroblastoma starts in the abdominal or chest area, which can cause symptoms like abdominal

swelling, constipation, diarrhea, difficulty breathing, chest pain, and a lump in the abdomen. In some

cases, neuroblastoma can also cause pain, particularly in the location of the tumor, along with fever,

fatigue, loss of appetite, weight loss, and other flu-like symptoms. As the tumor grows, it can affect

nearby systems and organs, causing complications such as skeletal abnormalities or bone pain, kidney

problems, or neurological symptoms like weakness, numbness, or paralysis. These symptoms may arise

due to pressure caused by the tumor, compression of nerves and blood vessels, or other physiological

changes caused by the cancer cells. Since neuroblastoma can be asymptomatic in its early stages, it is

important to seek medical advice if any of these symptoms are present, particularly if they persist or

worsen over time.

- Common signs and symptoms of neuroblastoma

Neuroblastoma can present a wide range of clinical signs and symptoms depending on the stage of

the disease and the location of the tumor. Firstly, there may be a visible mass or lump, typically in

the abdomen, neck, or pelvis. Secondly, affected children often report generalised fatigue, weight loss,

and fever. Thirdly, neurological symptoms such as numbness, pain, or weakness in the affected area are

common. Additionally, patients may experience blurred vision, drooping eyelids, or uncontrolled jerky

movements as a result of the tumor pressing against nerves in the brain or spinal cord. Urinary and bowel

incontinence are other neurological symptoms that are seen in some cases. Lastly, if the cancer spreads to

other parts of the body, symptoms such as bone pain, difficulty breathing, and unexplained bruising and

bleeding may occur. It is important to seek medical attention if a child experiences any of these symptoms.

- Changes in activity and behavior

As neuroblastoma progresses, the child may experience changes in activity and behavior. These changes

may be due to the location of the tumor or the cancerous cells spreading to other parts of the body. In some

cases, the child may become irritable, anxious, or have difficulty sleeping. They may also experience loss

of appetite, weight loss, and fatigue. Caregivers may notice that the child is less interested in activities

they once enjoyed or isn't as physically active as they used to be. This is because neuroblastoma affects the

autonomic nervous system, which controls involuntary bodily functions such as heart rate, blood pressure,

and breathing. This can lead to a decrease in energy levels and overall physical ability. It is important for

caregivers to consult with a healthcare provider if they notice any significant changes in a child's activity

or behavior, as early detection and treatment can increase the chances of a positive outcome.

- Body changes and physical symptoms

There are various physical symptoms and changes that can occur with neuroblastoma. Firstly, the tumor

itself can cause visible lumps or masses, often in the abdomen, neck, chest, or pelvis. The presence

of a lump may lead to pain, discomfort, or difficulty breathing, swallowing, or urinating. Additionally,

neuroblastoma can cause other physiological changes in the body. For instance, it may trigger nervous

system reactions like rapid heartbeat, high blood pressure, or sweating. Furthermore, neuroblastoma may

impact hormone levels in the body, leading to symptoms like weight loss, diarrhea, or constipation.

Some children with neuroblastoma may also develop Horner syndrome, which involves droopy eyelids,

constricted pupils, and decreased sweating on one side of the face. Ultimately, the appearance and severity

of physical symptoms will depend on various factors, such as the size and location of the tumor, its stage,

and how quickly it is growing. It's crucial to monitor the body for any changes and report them to a

healthcare professional as soon as possible.

One of the most important aspects in the diagnosis of neuroblastoma is the staging of the disease. Staging

refers to the process of determining how much the cancer has spread from its initial site to other parts

of the body. Accurate staging allows clinicians to better understand the prognosis for the patient and

choose the best treatment options. The International Neuroblastoma Staging System (INSS) is commonly

used to stage neuroblastoma. The system classifies tumors into six stages based on factors such as tumor

size and spread to nearby lymph nodes or distant organs. In addition to INSS, other staging systems

such as the International Neuroblastoma Risk Group (INRG) system have been developed to improve the

accuracy of neuroblastoma staging and guide treatment decisions. Staging is a crucial step in the diagnosis

and management of neuroblastoma, as it provides physicians with crucial information for developing

individualized and effective treatment plans.

III. Causes of Neuroblastoma

There are several factors that could cause the development of neuroblastoma in a person. Firstly, genetic

mutations in the cells that form the sympathoadrenal lineage, which is responsible for the development of

the adrenal gland and the sympathetic nervous system, could lead to neuroblastoma. Additionally, familial

predisposition to neuroblastoma has also been observed, indicating a possible hereditary component.

Exposure to environmental factors such as pesticides, chemical pollutants, and ionizing radiation has also

been linked to the development of neuroblastoma. Furthermore, certain medical conditions such as congenital

abnormalities in the development of the neural crest cells, or certain chromosomal abnormalities,

might also increase the likelihood of developing neuroblastoma. Finally, age is a significant risk factor for

neuroblastoma, as it predominantly affects infants and young children. Overall, identifying the root cause

of neuroblastoma is crucial in determining the appropriate course of treatment and improving prognosis.

- Risk factors for neuroblastoma

In conclusion, there are a number of risk factors that may contribute to the development of neuroblastoma.

These include genetic mutations, rare inherited conditions such as neurofibromatosis type 1, abnormalities

in fetal development, exposure to certain environmental toxins, and age. Children under the age of five are

most commonly affected by this rare form of cancer, which often begins in the adrenal glands or nerve

cells that are located near the spine. While there are risk factors that appear to increase the likelihood

of developing neuroblastoma, it is important to note that many cases of the disease occur in individuals

without any known risk factors. Further research is needed to better understand the complex interplay

of genetic and environmental factors that contribute to the development and progression of this disease,

which continues to pose a significant challenge to patients and healthcare providers worldwide.

- Genetic and environmental factors

Genetic and environmental factors play a significant role in the development of neuroblastoma. Neuroblastoma

is often caused by mutations or alterations in genes that control cell growth and division, leading

to the formation of abnormal cells known as neuroblasts. Additionally, environmental factors, such as

exposure to radiation or chemicals, can increase the risk of developing neuroblastoma. Interestingly,

some genetic mutations associated with neuroblastoma can be inherited from parents or can occur

spontaneously. Furthermore, studies have shown that certain environmental factors, such as maternal

smoking during pregnancy, may increase the risk of developing neuroblastoma in children. Understanding

the interplay between genetic and environmental factors is crucial in the diagnosis and treatment of

neuroblastoma, as it can aid in the identification of individuals who are at a high risk of developing the

disease and inform preventative measures.

- The role of family history and inheritance

In the case of neuroblastoma, family history and inheritance play a significant role in the development

of the disease. Several gene mutations have been identified as predisposing factors for neuroblastoma,

including mutations in the ALK, PHOX2B, and LIN28B genes. Additionally, studies have shown that

children with a family history of neuroblastoma are at an increased risk of developing the disease

themselves. These findings highlight the importance of genetic screening and counseling for families with

a history of neuroblastoma, as well as the need for continued research into the specific genetic factors

that contribute to the development of this disease. Furthermore, identifying genetic markers that increase

susceptibility to neuroblastoma could lead to improved preventative measures and targeted therapies for

patients with a higher risk of developing this cancer.

In addition to undergoing chemotherapy, radiation therapy, and surgery, some neuroblastoma patients may

also receive immunotherapy as part of their treatment plan. Immunotherapy involves using the body's

own immune system to fight cancer cells, either by boosting the immune system's natural abilities or by

using drugs that specifically target cancer cells. One type of immunotherapy that has shown promise for

neuroblastoma patients is called chimeric antigen receptor (CAR) T-cell therapy. This treatment involves

taking a patient's own T-cells (a type of white blood cell) and genetically engineering them to target and

kill cancer cells. The modified T-cells are then infused back into the patient, where they seek out and

destroy cancer cells throughout the body. While CAR T-cell therapy is still in the experimental stage

for neuroblastoma treatment, clinical trials have shown promising results in increasing survival rates and

improving quality of life for some patients.

IV. Diagnosis of Neuroblastoma

: The diagnosis of neuroblastoma involves a series of tests, including physical examination, blood and

urine tests, imaging studies such as X-rays, computed tomography (CT), magnetic resonance imaging

(MRI), and bone scans. Biopsy is the gold standard for the definitive diagnosis of neuroblastoma. In

biopsy, a small tissue sample is extracted from the tumor or nearby lymph nodes and examined under a

microscope to detect the presence of neuroblastoma cells. Additional tests, such as chromosomal analysis,

immunohistochemistry, and molecular testing, may also be conducted to determine the genetic profile of

the tumor and guide treatment decisions. The staging system commonly used for neuroblastoma is the

International Neuroblastoma Staging System, which takes into account factors such as the location of the

tumor, extent of spread, age of the patient, and certain biological markers. Early detection and accurate

diagnosis of neuroblastoma are crucial for effective treatment and improved outcomes.

- Diagnostic tests and procedures

Diagnostic tests and procedures play a key role in diagnosing neuroblastoma. Imaging studies such as

X-rays, ultrasounds, CT scans, and MRIs can help identify the location and size of tumors. Bone scans

and MIBG scans can detect if cancer has spread to the bones or other organs. Biopsies involve removing

a sample of tumor tissue for examination under a microscope, which can confirm the diagnosis of

neuroblastoma. Blood and urine tests can also be used to detect the presence of certain substances, such as

catecholamines and neuron-specific enolase, which are often elevated in individuals with neuroblastoma.

Genomic testing can also be used to identify genetic mutations that are associated with the development of

neuroblastoma. Ultimately, a combination of these diagnostic tests and procedures can provide healthcare

providers with the information they need to determine the best course of treatment for individuals with

neuroblastoma.

- Imaging studies such as MRI, CT scans or X-rays

Imaging studies such as MRI, CT scans or X-rays are crucial in determining the extent and location

of a neuroblastoma. CT scans provide a detailed view of the abdomen, chest, and pelvis, as well as

detect any possible spread of cancer to the bones. MRI scans, on the other hand, are better suited for

visualizing the soft tissues and nerves surrounding the tumor. As neuroblastomas tend to spread to the

bones, a bone scan is also often recommended to evaluate the extent of involvement. Moreover, MIBG

(metaiodobenzylguanidine) scans are highly sensitive and specific in detecting neuroblastomas, especially

those that have spread to other parts of the body. It is critical that imaging studies are used in conjunction

with other diagnostic approaches to ensure the proper diagnosis of a neuroblastoma. The results of

imaging studies can help doctors determine the stage of the cancer, which is crucial in making treatment

decisions. These scans also help in evaluating the effectiveness of treatment and keep track of potential

recurrences.

- Biopsy as a diagnostic tool

Biopsy is the gold standard diagnostic tool for neuroblastoma. A biopsy involves the removal of a tissue

sample from the affected area for examination by a pathologist. The tissue samples can be obtained from

various methods, such as fine needle aspiration, core needle biopsy, or open surgical biopsy. The biopsy

helps confirm the diagnosis of neuroblastoma by analyzing the tumor cells and their characteristics under

a microscope. The tumor cells are examined for various features, such as their size, shape, type, and

presence of specific markers. Biopsy provides critical information, such as the extent of the disease, tumor

staging, and genetic mutations that may impact treatment options. It also helps differentiate neuroblastoma

from other similar tumors and diagnoses that may present with similar symptoms. Despite its usefulness

in diagnosis, biopsies do carry risks, such as bleeding, infection, or wound healing. Therefore, careful

consideration is given before proceeding with a biopsy and is usually done under the guidance of an

experienced surgeon.

One factor that complicates the treatment of neuroblastoma is its tendency to progress and spread

rapidly. Tumor growth frequently involves surrounding tissue and organs, which can result in extensive

damage and life-threatening complications. Additionally, metastasis to other areas of the body can occur,

particularly to the bone and bone marrow. Unfortunately, the signs and symptoms of neuroblastoma are

often not apparent until the disease has advanced. In many cases, by the time a diagnosis is made, the

cancer has already spread. This underscores the importance of regular medical check-ups, particularly

for young children who may not be able to communicate their symptoms clearly. Early detection and

intervention are key to improving treatment outcomes. Nevertheless, even when the cancer has spread,

there are a variety of treatment options available, including chemotherapy, radiation therapy, surgery, and

stem cell transplantation, that can significantly extend the lifespan of patients with neuroblastoma.

V. Treatment for Neuroblastoma

V. Treatment for neuroblastoma depends on a variety of factors such as the stage and location of

the tumor, age of the patient, and overall health status. Surgery is often the mainstay of treatment in

early-stage tumors while chemotherapy and radiation therapy are commonly used in more advanced

cases. Other treatment options include immunotherapy, targeted therapy, stem cell transplant, and clinical

trials for experimental treatments. The goal of treatment is to achieve complete remission of the tumor

and prevent recurrence. However, the side effects of treatment can be significant and may include

fatigue, nausea, hair loss, and increased risk of infection. Long-term survivors of neuroblastoma may

also face complications related to treatment such as hearing loss, reduced lung function, and growth

delays. Therefore, individualized treatment plans and ongoing monitoring of patients’ health are crucial

to optimize outcomes and quality of life.

- Different treatment options for neuroblastoma

The best possible treatment for neuroblastoma varies in every individual case, taking into account various

factors such as age, stage of the disease, and the severity of symptoms. Surgical excision of the tumor is

recommended if it is localized, even though this may be challenging in some cases, especially if the tumor

is near vital organs. Radiation therapy can also be used to eliminate residual cancer cells after surgery.

Chemotherapy is an important treatment option for high-risk neuroblastoma, as it targets cancer cells

throughout the body. Immunotherapy is a relatively new treatment option that involves the bolstering of

the immune system to fight the cancer cells effectively. Also, targeted therapy or precision medicine is

the latest form of treatment, which involves medications designed to attack specific cancer cells. Finally,

patients who have reached late stages of the illness or those who have not responded to other treatments

can benefit from palliative care, which aims to alleviate symptoms and strengthen quality of life.

- Surgery as a treatment for neuroblastoma

Surgery is also a common treatment for neuroblastoma, although it is often used in combination with other

therapies. The goal of surgery is to remove as much of the tumor as possible while preserving important

organs and tissues. This can be a delicate and complex procedure, particularly if the tumor is located in

a sensitive area of the body such as the brain or spinal cord. In some cases, surgeons may also remove

nearby lymph nodes as a precautionary measure, as they can be a site of cancer spread. In general, surgery

is most effective when used in combination with chemotherapy and radiation therapy, as these treatments

can help to shrink the tumor before surgery and prevent it from coming back afterwards. Despite its

potential benefits, surgery does carry some risk of complications such as infection, bleeding, and nerve

damage, and patients will need to be carefully monitored and supported throughout the recovery process.

- Chemotherapy and radiation therapy as a treatment for neuroblastoma

Chemotherapy and radiation therapy are two common treatments for neuroblastoma. Chemotherapy

involves the use of drugs to kill cancer cells and prevent them from multiplying. There are several types of

chemotherapy drugs that are used to treat neuroblastoma, including cisplatin, carboplatin, etoposide, and

cyclophosphamide. Radiation therapy, on the other hand, involves the use of high-energy radiation to kill

cancer cells. This type of therapy can be delivered externally or internally depending on the location and

stage of the tumor. During external beam radiation therapy, a machine delivers radiation to the affected

area. In contrast, internal radiation therapy involves the insertion of radioactive material directly into

the tumor. While both chemotherapy and radiation therapy have proven to be effective treatments for

neuroblastoma, they often come with side effects that vary depending on the patient and specific treatment

plan. It's important to note that a multidisciplinary approach that combines various treatment options is

often more effective in treating neuroblastoma.

In addition to chemotherapy and surgery, radiation therapy can also be used to treat neuroblastoma.

Radiation therapy uses high-energy x-rays to kill cancer cells. It may be delivered externally using a

machine outside the body (external beam radiation therapy) or internally through a radioactive source

placed inside the body near the tumor (brachytherapy). Radiation therapy is often used after surgery to

eliminate any remaining cancer cells and decrease the risk of the cancer recurring. It may also be used

before surgery to shrink the tumor, making it easier to remove. However, radiation therapy can also cause

side effects such as nausea, skin irritation, and fatigue. Additionally, long-term side effects such as growth

problems, hearing loss, and cognitive impairment may occur in children who receive radiation therapy

to the head and neck area. Therefore, doctors carefully weigh the benefits and risks of radiation therapy

before recommending it as a treatment for neuroblastoma.

VI. Conclusion

In conclusion, neuroblastoma is a rare and aggressive cancer that primarily affects children under the

age of five. Although the exact cause of this cancer is unknown, studies show that genetic mutations

and environmental factors may play a role in its development. Symptoms of neuroblastoma can vary

depending on the location of the tumor and may include abdominal pain, lump or mass, loss of appetite,

and bone pain. Early diagnosis is crucial for proper treatment and can be achieved through a combination

of imaging tests, biopsies, and blood tests. The available treatment options for neuroblastoma include

surgery, chemotherapy, radiation therapy, and targeted therapy. However, the choice of treatment depends

on the severity of the cancer and the child’s overall health. With proper treatment and care, the survival

rates for neuroblastoma have improved over the years. Nonetheless, the long-term effects of treatment

remain a concern, and continuous research is needed to develop better treatment options with fewer side

effects.

- Recap of symptoms, causes, diagnosis and treatment of neuroblastoma

Neuroblastoma is a rare form of childhood cancer that often goes unrecognized until it has spread to

other parts of the body. Symptoms of this disease include abdominal swelling, frequent infections, trouble

breathing, and excessive fatigue. The causes of neuroblastoma are not yet fully understood, but studies

suggest that genetic mutations, exposure to certain chemicals, and environmental factors could play a role

in its development. Diagnosis of this condition usually requires an initial examination followed by a series

of tests such as blood tests, bone scans, and CT scans. Treatment options range from surgery to remove

the tumor to chemotherapy and radiation therapy. In some cases, immunotherapy may also be used to

stimulate the immune system and fight cancer cells. Overall, early detection and treatment are crucial

in managing the symptoms of neuroblastoma and improving the chances of survival for those diagnosed

with this disease.

- The importance of early detection and treatment

Early detection and treatment of neuroblastoma is critical for achieving successful outcomes. The

symptoms of neuroblastoma are often non-specific and can be mistaken for other conditions. Therefore,

it is important for parents and pediatricians to be vigilant about any changes in a child's health. Early

diagnosis through routine screening and imaging tests can help detect neuroblastoma in its early stages

when it is most treatable. Treatment options for neuroblastoma include surgery, chemotherapy, radiation,

and stem cell transplant depending on the stage and severity of the disease. Early treatment can prevent

the cancer from spreading to other parts of the body and improve the chances of a positive outcome. With

timely detection and treatment, the survival rate for neuroblastoma can be greatly improved. For this

reason, it is important for parents and healthcare professionals to prioritize early detection and treatment

of neuroblastoma to ensure the best possible outcomes for affected children.

- The outlook for patients with neuroblastoma.

Despite the complex nature of neuroblastoma, advancements in research and treatment have improved

the outlook for patients. The five-year survival rate has increased to around 70%, with some patients

experiencing long-term remission. Several factors influence the prognosis, including the age of onset,

stage, genetics, and response to treatment. Infants diagnosed before six months tend to have better

outcomes, while those with advanced stages or aggressive genetic markers face a more challenging prognosis.

Treatment options vary depending on the risk level, but generally involve combination therapies

such as chemotherapy, surgery, radiation, and immunotherapy. High-risk patients may undergo stem cell

transplantation or receive targeted therapies such as GD2-antibodies or chimeric antigen receptor (CAR)

T-cell therapy. Despite these interventions, some patients may experience relapse or resistant disease,

underscoring the need for continued research and development of novel treatments. Overall, the outlook

for patients with neuroblastoma has improved significantly but still requires ongoing monitoring and

appropriate management to achieve the best possible outcomes.

Bibliography

- Junnu Leikola. 'Sentinel Lymph Node Biopsy as a Diagnostic Tool in the Treatment of Breast Cancer.'

Junnu Leikola, 1/1/2008

- Michael A. Bruno. 'Error and Uncertainty in Diagnostic Radiology.' Oxford University Press, 2/8/2018

- Barbara J. Berger. 'Laboratory Tests and Diagnostic Procedures.' Cynthia C. Chernecky, Elsevier/

Saunders, 1/1/2013

- Rachel A. Ormsby. 'Dancing in the Rain.' A Parent's Guide to Neuroblastoma Diagnosis, Treatment

and Beyond, Dancing in the Rain, 6/27/2013

- New York-Mid-Atlantic Consortium for Genetic and Newborn Screening Services. 'Understanding

Genetics.' A New York, Mid-Atlantic Guide for Patients and Health Professionals, Genetic Alliance,

Lulu.com, 1/1/2009

- A.S. Parkes. 'Genetic and Environmental Factors in Human Ability.' A Symposium held by the

Eugenics Society in September—October 1965, James E. Meade, Springer, 12/14/2013

- Mary E. Shepherd. 'A Case-control Study of Perinatal and Parental Risk Factors for Neuroblastoma.'

University of Massachusetts at Amherst, 1/1/1989

- Food and Nutrition Board. 'Educating the Student Body.' Taking Physical Activity and Physical Education

to School, Committee on Physical Activity and Physical Education in the School Environment,

National Academies Press, 11/13/2013

- American College of Sports Medicine. 'ACSM's Behavioral Aspects of Physical Activity and Exercise.'

Lippincott Williams & Wilkins, 8/20/2013

- Dr Micheal Samuel. 'Neuroblastoma.' The Ultimate Secret of Neuroblastoma, Amazon Digital

Services LLC - Kdp, 2/22/2023

- Patrick Kimuyu. 'Pathophysiology of Neuroblastoma.' GRIN Verlag, 1/29/2018

- Carl E. Pochedly. 'Neuroblastoma.' CRC Press, 6/21/1990

- Chandrika Gowda. 'Neuroblastoma.' Current State and Recent Updates, BoD – Books on Demand,

10/25/2017

People also ask

What is the cause of neuroblastoma?

What is the main treatment for neuroblastoma?

When is neuroblastoma usually diagnosed?

What are the symptoms of neuroblastoma presentation?

How is neuroblastoma diagnosed?

What causes neuroblastoma in children?

What are the different types of neuroblastoma?

What is the neuroblastoma?

What are the stages of neuroblastoma?

What type of tumor is neuroblastoma?

How can you prevent neuroblastoma?

Where is a neuroblastoma located?

Who is neuroblastoma most common in?

What is stage 4 neuroblastoma in children?

What are the diagnostic tools for neuroblastoma?

How long is treatment for neuroblastoma?

How do you treat stage 4 neuroblastoma?

Who is at risk for neuroblastoma?